Free Trial
LON:TRS

Tarsus Group (TRS) Share Price, News & Analysis

Tarsus Group logo

About Tarsus Group Stock (LON:TRS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
424
424
52-Week Range
N/A
Volume
215,764 shs
Average Volume
272,972 shs
Market Capitalization
£549.84 million
P/E Ratio
45.59
Dividend Yield
2.59%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tarsus Group and its competitors with MarketBeat's FREE daily newsletter.

TRS Stock News Headlines

Tarsus Stock Price History
Tarsus Pharmaceuticals price target raised to $41 from $36 at Goldman Sachs
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.
Earnings Outlook For Tarsus Pharmaceuticals
TRS Yucatan Hotel
See More Headlines

TRS Stock Analysis - Frequently Asked Questions

Shares of TRS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tarsus Group investors own include Avery Dennison (AVY), Aviva (AV), Fidelity Japan Trust (FJV), Hotel Chocolat Group (HOTC), HSBC (HSBA), Primary Health Properties (PHP) and Royal Dutch Shell (RDSB).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Advertising Agencies
Sub-Industry
Fabricated Products
Current Symbol
LON:TRS
CIK
N/A
Fax
N/A
Employees
3,500
Year Founded
N/A

Profitability

Trailing P/E Ratio
45.59
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£99.73 million
Price / Cash Flow
19.27
Book Value
GBX 77.80 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
£549.84 million
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (LON:TRS) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners